Kids struggle with asthma as much at school as they do at home — possibly even more so, since it can be tough for them to access their medicine. So why aren’t all schools offering them asthma therapy? A new study says that school-based asthma therapy is effective in helping kids breathe easier while away from home. These school programs keep kids healthier, and can save millions in health care costs, researchers report in the May issue of the Journal of Allergy and Clinical Immunology: Global. “We help families get better adherence to kids’ asthma control medication regimens by having the school nurses give them their meds on the days that they go to school,” lead researcher Kimberly Arcoleo, a professor at the Michigan State University College of Nursing, said in a news release. For the study, researchers tracked a school-based asthma therapy program implemented in two Columbus, Ohio, school districts between 2013 and 2019, involving 633 kids ranging in age from 5 to 19. “Students get two inhalers with controller medication, one that goes to school and one that stays home so it doesn’t have to move back and forth,” Arcoleo said. “The school nurse administers the medication to the kids each school day according to their health care provider’s instructions. Some kids need it once a day, some need it twice a day.”…  read on >  read on >

Loneliness among seniors has been a huge concern among experts on aging as social isolation increases risk of dementia, health problems, psychological disorders and deaths. But a new study suggests that, at least in the U.S., that concern has been somewhat misplaced. Middle-aged people in the United States experience more loneliness than seniors, researchers reported today in the journal Aging and Mental Health. The Netherlands is the only other country where loneliness is more concentrated among the middle-aged than seniors, according to the study’s review of more than 64,000 people in 29 countries. “There is a general perception that people get lonelier as they age, but the opposite is actually true in the U.S. where middle-aged people are lonelier than older generations,” lead researcher Robin Richardson, a social and psychiatric epidemiologist and assistant professor at Emory University’s Rollins School of Public Health, said in a news release. “Advocacy and interventions to address the loneliness epidemic have historically focused on older adults and adolescents,” she added. “Middle-aged adults represent a critical population that is being overlooked.” For the study, researchers assessed data from surveys conducted in Europe, the Middle East and North America that included a three-question loneliness scale developed by UCLA. Results showed that loneliness generally increased with age, with the most substantial increases in the Eastern European countries Bulgaria and Latvia. Adults in Cyprus…  read on >  read on >

Loneliness among seniors has been a huge concern among experts on aging as social isolation increases risk of dementia, health problems, psychological disorders and deaths. But a new study suggests that, at least in the U.S., that concern has been somewhat misplaced. Middle-aged people in the United States experience more loneliness than seniors, researchers reported today in the journal Aging and Mental Health. The Netherlands is the only other country where loneliness is more concentrated among the middle-aged than seniors, according to the study’s review of more than 64,000 people in 29 countries. “There is a general perception that people get lonelier as they age, but the opposite is actually true in the U.S. where middle-aged people are lonelier than older generations,” lead researcher Robin Richardson, a social and psychiatric epidemiologist and assistant professor at Emory University’s Rollins School of Public Health, said in a news release. “Advocacy and interventions to address the loneliness epidemic have historically focused on older adults and adolescents,” she added. “Middle-aged adults represent a critical population that is being overlooked.” For the study, researchers assessed data from surveys conducted in Europe, the Middle East and North America that included a three-question loneliness scale developed by UCLA. Results showed that loneliness generally increased with age, with the most substantial increases in the Eastern European countries Bulgaria and Latvia. Adults in Cyprus…  read on >  read on >

People might think they can reduce their risk of cancer by occasionally swapping their cigarettes for a vape pen — but they would be wrong, a new study says. So-called “dual users” — folks who both smoke and vape – are exposed to the same levels of nicotine and cancer-causing toxins as those who only smoke cigarettes, researchers reported in the journal Nicotine and Tobacco Research. “In the U.S., dual-use of combustible cigarettes and e-cigarettes is the most common multiple tobacco-use behavior. Some individuals try to cut back on cigarettes or work toward quitting cigarettes this way,” lead researcher Zheng (Ashley) Xue, a senior associate scientist of tobacco control research at the American Cancer Society, said in a news release. “However, our results highlight that dual-use is not an effective way to safeguard health and more evidence that tobacco use is harmful,” she added. For the study, researchers analyzed data for nearly 2,700 adults participating in a federal study of the long-term effects of tobacco use. Results showed that dual-users and cigarette smokers had higher levels of a tobacco-specific nitrosamine — an organic substance that is a probable cause of cancer — than people who exclusively vaped. Dual-users also had higher levels of three volatile organic compounds that have been linked to cancer, the study said. “Clinicians and public health practitioners should increase awareness that dual…  read on >  read on >

People might think they can reduce their risk of cancer by occasionally swapping their cigarettes for a vape pen — but they would be wrong, a new study says. So-called “dual users” — folks who both smoke and vape – are exposed to the same levels of nicotine and cancer-causing toxins as those who only smoke cigarettes, researchers reported in the journal Nicotine and Tobacco Research. “In the U.S., dual-use of combustible cigarettes and e-cigarettes is the most common multiple tobacco-use behavior. Some individuals try to cut back on cigarettes or work toward quitting cigarettes this way,” lead researcher Zheng (Ashley) Xue, a senior associate scientist of tobacco control research at the American Cancer Society, said in a news release. “However, our results highlight that dual-use is not an effective way to safeguard health and more evidence that tobacco use is harmful,” she added. For the study, researchers analyzed data for nearly 2,700 adults participating in a federal study of the long-term effects of tobacco use. Results showed that dual-users and cigarette smokers had higher levels of a tobacco-specific nitrosamine — an organic substance that is a probable cause of cancer — than people who exclusively vaped. Dual-users also had higher levels of three volatile organic compounds that have been linked to cancer, the study said. “Clinicians and public health practitioners should increase awareness that dual…  read on >  read on >

Folks with asthma might better control their symptoms by precisely timing when they use their inhaler, a new study says. A single daily preventive dose of inhaled corticosteroid is best taken at mid-afternoon for effective asthma control, researchers reported April 15 in the journal Thorax. That timing will suppress the usual nighttime worsening of symptoms better than using an inhaler at other times of the day, researchers said. They said the perfect timing is 4 p.m., as the body is most responsive to inhaled steroids at that time. “Mid-afternoon dosing … better improved nocturnal lung function and inflammatory biomarkers compared with the alternative dosage timings,” concluded the research team led by Hannah Jane Durrington, a clinician scientist at the University of Manchester in the U.K.. For the study, researchers followed 25 people ages 18 to 65 with mild to moderate asthma, who were randomly assigned to one of three different dosing regimens. Some took a daily inhaler dose between 8 a.m. and 9 a.m.; others a daily dose between 3 p.m. and 4 p.m.; and the rest took two doses — one between 8 a.m. and 9 a.m. and the second between 8 p.m. and 9 p.m. Folks stayed on their assigned regimen for 28 days, then swapped to a different one after a two- to three-week gap. By the end, all participants had tried…  read on >  read on >

Folks with asthma might better control their symptoms by precisely timing when they use their inhaler, a new study says. A single daily preventive dose of inhaled corticosteroid is best taken at mid-afternoon for effective asthma control, researchers reported April 15 in the journal Thorax. That timing will suppress the usual nighttime worsening of symptoms better than using an inhaler at other times of the day, researchers said. They said the perfect timing is 4 p.m., as the body is most responsive to inhaled steroids at that time. “Mid-afternoon dosing … better improved nocturnal lung function and inflammatory biomarkers compared with the alternative dosage timings,” concluded the research team led by Hannah Jane Durrington, a clinician scientist at the University of Manchester in the U.K.. For the study, researchers followed 25 people ages 18 to 65 with mild to moderate asthma, who were randomly assigned to one of three different dosing regimens. Some took a daily inhaler dose between 8 a.m. and 9 a.m.; others a daily dose between 3 p.m. and 4 p.m.; and the rest took two doses — one between 8 a.m. and 9 a.m. and the second between 8 p.m. and 9 p.m. Folks stayed on their assigned regimen for 28 days, then swapped to a different one after a two- to three-week gap. By the end, all participants had tried…  read on >  read on >

Pfizer has stopped developing a once-daily pill to treat obesity after a person in a clinical trial showed signs of a possible liver injury. The company said the injury went away after the person stopped taking the drug, called danuglipron, The Associated Press reported. The pill was in early testing to help determine the best dose, according to a Pfizer spokeswoman. The company had planned to move the drug into late-stage trials, typically the final step before review by the U.S. Food and Drug Administration (FDA). Pfizer will now stop all testing of danuglipron, including its use with other drugs for obesity treatment. However, the company said it still plans to work on other obesity treatments that are in earlier stages of research. Obesity drugs have become a major focus for pharmaceutical companies. Injectable treatments like Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy have brought in billions in revenue. Zepbound earned nearly $5 billion in 2024 alone, The Associated Press reported. But these drugs must be injected, which some people do not want to do. As a result, drugmakers have been racing to develop pill versions. Lilly expects to release new data this year on two oral obesity drugs it is studying. While demand for these treatments is high, access has been an issue. Some patients face insurance issues or high out-of-pocket costs. Even with…  read on >  read on >

Early symptoms of menopause will first appear when many women least expect them, a new Ohio State University poll reports. Hot flashes, mood swings, weight gain and insomnia are all symptoms of the hormone changes related to menopause, researchers say. Sixty-one percent of women (3 in 5) think they will hit menopause and start experiencing these symptoms in their 40s, according to poll results from the Ohio State University Wexner Medical Center. But that just isn’t so, doctors say. In fact, most women won’t see their menopause start until their early 50s, while some will begin to experience symptoms as soon as their 30s,  “Perimenopause is when the menstrual cycle has started to change, and it is persistent,” Dr. Lauren Baker, a specialist in obstetrics and gynecology at Wexner, said in a news release. “The formal definition is periods fluctuate by at least seven days for at least 10 months.” Women shouldn’t shrug off symptoms just because they think they’re too young for menopause, Baker said. Every woman’s menopause is different, and that’s why it’s important to bring any changes or concerns to a doctor’s attention. On the other hand, half of the women surveyed (52%) think diet and exercise can help treat menopause symptoms — and that’s spot on, experts say. “Having a diet that’s rich in calcium and vitamin D is really important…  read on >  read on >

Brain diseases like stroke, dementia and depression share common risk factors, and changing any can lower a person’s risk of all three conditions, a new study says. Addressing factors as varied as blood pressure, blood sugar, cholesterol, physical activity, sleep, stress, alcohol consumption and smoking can significantly reduce risk of the three age-related brain diseases, researchers reported in the Journal of Neurology, Neurosurgery and Psychiatry. “Our study identified 17 modifiable risk factors shared between stroke, dementia, and/or late-life depression, emphasizing that there are many different steps individuals can take to lower their risks for these age-related brain diseases,” senior researcher Dr. Sanjula Singh, principal investigator at the Brain Care Labs at Massachusetts General Hospital in Boston, said in a news release. At least 60% of strokes, 40% of dementia cases, and 35% of late-life depression diagnoses are linked to lifestyle-related risk factors, researchers said in background notes. “Dementia, stroke, and late-life depression are connected and intertwined, so if you develop one of them, there’s a substantial chance you may develop another one in the future,” said lead researcher Dr. Jasper Senff, a postdoctoral fellow at the MGH Brain Care Labs. To hone in on what makes a difference, researchers pooled data from 59 previous studies of risk factors related to brain health. From these studies, researchers identified risk factors shared by at least two of…  read on >  read on >